Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-25-038985
Filing Date
2025-08-07
Accepted
2025-08-07 17:12:02
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 ginkgo-sx3aug2025.htm S-3 193184
2 exhibit107.htm   iXBRL EX-FILING FEES 47889
3 EX-5.1 exhibit51-sx3.htm EX-5.1 20190
4 EX-23.1 exhibit231-sx3.htm EX-23.1 2318
5 EX-23.3 exhibit233-sx3.htm EX-23.3 2466
6 ginkgobiologoa.jpg GRAPHIC 6914
7 header.jpg GRAPHIC 4642
  Complete submission text file 0001628280-25-038985.txt   451194

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT exhibit107_htm.xml XML 16647
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289390 | Film No.: 251195296
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)